Every year, they are in charge of about one-third of all deaths – roughly 3. 5 million people – according to the global world Health Organization. Globally, over half of a million people passed away from malaria, and about 1 million people died from tuberculosis in 2012. In the U.S., HIV, pneumonia and influenza are among the leading causes of infectious diseases deaths. New diseases are emerging, and those thought to be in order are re-emerging. Microbial resistance to known drugs is increasing, leaving physicians with few or no selections for treating many patients.As a total result, it is becoming difficult to treat infected patients successfully increasingly. The Academy of Sciences and Humanities in Hamburg and the German National Academy of Sciences Leopoldina resolved this issue in their joint statement, ‘Antibiotics Research: Complications and Perspectives’ in January 2013. The paper is now available in English, just with time when the topic can be on the agenda of the G8 summit. The academies list eight suggestions that show methods to prevent the further spread of antibiotic resistance also to develop urgently needed antibiotics. Related StoriesArchbishop of York agrees to be Antibiotic Research UK's PatronAntibiotic resistance potentially threatens the security and efficacy of surgical treatments and immunosuppression therapiesNew broad-spectrum antibiotic may kill bacteria by punching holes in their membranes ‘This advancement is a trigger for grave concern.